Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

A phase II study for metabolic in vivo response monitoring with sequential 18FDG-PET-CT during treatment with the EGFR-monoclonal-antibody cetuximab in metastatic colorectal cancer: the Heidelberg REMOTUX trial

  • Anne Katrin Berger1Email author,
  • Carl von Gall2,
  • Ulrich Abel1, 8,
  • Stefan Delorme3,
  • Matthias Kloor4,
  • Jennifer Ose1,
  • Tim Frederik Weber5,
  • Annika Stange1,
  • Georg Martin Haag1,
  • Uwe Haberkorn6,
  • Florian Lordick7 and
  • Dirk Jäger1
BMC Cancer201212:108

DOI: 10.1186/1471-2407-12-108

Received: 23 January 2012

Accepted: 22 March 2012

Published: 22 March 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
23 Jan 2012 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
2 Feb 2012 Author responded Author comments - Anne Katrin Berger
Resubmission - Version 3
2 Feb 2012 Submitted Manuscript version 3
3 Mar 2012 Reviewed Reviewer Report - Dirk Vordermark
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
22 Mar 2012 Editorially accepted
22 Mar 2012 Article published 10.1186/1471-2407-12-108

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article.. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
National Center for Tumor Diseases (NCT), University Medical Center Heidelberg
(2)
Department of Nuclear Medicine, University Hospital Erlangen
(3)
Department of Radiology, German Cancer Research Center
(4)
Department of Applied Tumor Biology, University Medical Center Heidelberg
(5)
Department of Diagnostic and Interventional Radiology, University Medical Center Heidelberg
(6)
Department of Nuclear Medicine, University Medical Center Heidelberg
(7)
Department of Oncology and Hematology, Hospital of Braunschweig
(8)
Institute of Medical Biometry and Informatics, University Medical Center of Heidelberg

Advertisement